Ying-li Yang
The Key Laboratory Of Anti Inflammatory And Immune Medicines
Hefei, 230032, China
Hefei, 230032, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
GPR161 contributes to macrophage glycolytic reprogramming via targeting C5aR1 in acute lung injury.
Journal: Cellular & molecular biology letters
Published: August 06, 2025
N-(4-methoxyphenyl) quinoline-8-sulfonamide reduces the inflammatory response of fibroblast-like synoviocytes by targeting receptor (calcitonin) activity modifying protein 1 in rheumatoid arthritis.
Journal: European journal of pharmacology
Published: July 12, 2024
Rab11b promotes M1-like macrophage polarization by restraining autophagic degradation of NLRP3 in alcohol-associated liver disease.
Journal: Acta pharmacologica Sinica
Published: March 03, 2024
Roles of interferon induced protein with tetratricopeptide repeats (IFIT) family in autoimmune disease.
Journal: Autoimmunity reviews
Published: September 02, 2023
Hesperetin derivative 2a inhibits lipopolysaccharide-induced acute liver injury in mice via downregulation of circDcbld2.
Journal: Acta pharmacologica Sinica
Published: June 05, 2023
The Role of CCL3 in the Pathogenesis of Rheumatoid Arthritis.
Journal: Rheumatology and therapy
Published: March 17, 2023
7-O-(2- (Propylamino)-2-oxoethyl) hesperetin attenuates inflammation and protects against alcoholic liver injury by NLRP12.
Journal: International immunopharmacology
Published: May 11, 2022
PPAR-γ alleviates the inflammatory response in TNF-α-induced fibroblast-like synoviocytes by binding to p53 in rheumatoid arthritis.
Journal: Acta pharmacologica Sinica
Published: March 24, 2022
PLCL1 regulates fibroblast-like synoviocytes inflammation via NLRP3 inflammasomes in rheumatoid arthritis.
Journal: Advances in rheumatology (London, England)
Published: December 13, 2021
Showing 1-9 of 9
Last Updated: 09/26/2026